Ticker Details
Inhibrx, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.17 | 3.73%
Avg Daily Range (30 D):	$2.99 | 3.29%
Avg Daily Range (90 D):	$3.98 | 3.89%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.18M
Avg Daily Volume (90 D):	.31M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	37
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	1,525
Avg Institutional Trade:	$2.47M
Avg Institutional Trade (30 D):	$3.06M
Avg Institutional Trade (90 D):	$4.91M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.36M
Avg Closing Trade (30 D):	$2.31M
Avg Closing Trade (90 D):	$3.8M
Avg Closing Volume:	70.47K

News

May 14, 2026 @ 8:02 PM Inhibrx Reports First Quarter 2026 Financial Resul... Source: Prnewswire

Apr 22, 2026 @ 6:20 PM Large Drugmakers Eye Inhibrx Cancer Drugs Valued O... Source: Vandana Singh

Oct 24, 2025 @ 5:22 PM Stocks Soar To Records After Weak Inflation, Ford ... Source: Piero Cingari

Oct 24, 2025 @ 7:05 AM Why Are Inhibrx Biosciences Shares Soaring 76% Aft... Source: Mohd Haider

Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-8.88	$-2.34	$-2.15
Diluted EPS	$-8.88	$-2.34	$-2.15
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-138.18M	$-36.65M	$-33.44M
Operating Income / Loss	$-127.81M	$-32.15M	$-30.93M
Cost of Revenue
Net Cash Flow	$-62.35M	$M	$M
PE Ratio